Pharmacists’ assessment and management of acute and chronic gout

[1]  A. Qaseem,et al.  Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians. , 2017, Annals of internal medicine.

[2]  M. Weisman,et al.  Treat-to-target (T2T) recommendations for gout , 2016, Annals of the rheumatic diseases.

[3]  F. Becce,et al.  2016 updated EULAR evidence-based recommendations for the management of gout , 2014, Annals of the rheumatic diseases.

[4]  A. Avins,et al.  A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial. , 2016, The Permanente journal.

[5]  Kwang-Hoon Lee,et al.  Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease , 2015, The Journal of Rheumatology.

[6]  K. Anstrom,et al.  Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The EXACT-HF Study , 2015 .

[7]  L. Harrold,et al.  Overcoming adherence issues and other barriers to optimal care in gout , 2015, Current opinion in rheumatology.

[8]  M. Doherty,et al.  Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study , 2014, BDJ.

[9]  R. Terkeltaub,et al.  2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis , 2012, Arthritis care & research.

[10]  Charles King,et al.  2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia , 2012, Arthritis care & research.

[11]  Sharon C May.  University of British Columbia Conference on Dementia 2011 , 2011 .

[12]  M. Ernst,et al.  Management of gout in the older adult. , 2011, The American journal of geriatric pharmacotherapy.

[13]  L. Stamp,et al.  The Challenges of Gout Management in the Elderly , 2011, Drugs & aging.

[14]  D. Goldfarb,et al.  Prevalence of contraindications and prescription of pharmacologic therapies for gout. , 2011, The American journal of medicine.

[15]  R. Terkeltaub,et al.  High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. , 2010, Arthritis and rheumatism.

[16]  F. Perez-Ruiz,et al.  Treating to target: a strategy to cure gout. , 2009, Rheumatology.

[17]  R. Hunt,et al.  Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks , 2009, Alimentary pharmacology & therapeutics.

[18]  L. Kuller,et al.  Long-term cardiovascular mortality among middle-aged men with gout. , 2008, Archives of internal medicine.

[19]  M. Underwood.  Sugary drinks, fruit, and increased risk of gout , 2008, BMJ : British Medical Journal.